Study: Use total CVD risk to determine hypertension treatment

08/19/2014 | Medscape (free registration)

A patient's total cardiovascular disease risk, instead of just blood-pressure readings, should be the determining factor for initial treatment of hypertension, researchers from Uppsala University in Sweden reported in the Lancet. An accompanying editorial said more research is needed because some data in the meta-analysis was a decade old and the studies included only a small number of mildly hypertensive patients.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT